GAP-f lead @ WHO. Infectious disease specialist committed to maternal & child health. Foodie, orchids whisperer, traveller and art lover. Tweets are my own
Geneva, Switzerland
Joined November 2014
- Tweets358
- Following221
- Followers340
- Likes721
Martina Penazzato retweeted
📢 Looking ahead to #WHA78?
We're joining @gap_f_Network’s key side event on 20 May in Geneva:
"Strengthening the Ecosystem for Paediatric Medicines"
🕡 18:30–20:30 CEST | Jardin de Penthes
The new 2025–2030 strategy will also be launched. Don’t miss it.
🔗 Register here: bit.ly/43TYOG9
#BetterMeds4Kids
Martina Penazzato retweeted
🌍 "Getting the world back on track: Ending AIDS by 2030 still possible!"
If you're attending #WHA78, join our side event on 19 May, 19:30 CEST.
Stakeholders from IAS, @gnpplus, @PATHtweets & @WHO will explore funding, service delivery & innovations.
🔗 apps.who.int/gb/Side-Events/…
Martina Penazzato retweeted
🔍 New study reveals critical gaps in paediatric medicines on national essential medicines lists—especially in LMICs.
Our children’s health is at risk. This is why our collective work is more important than ever.
🚨 It's time for equitable access to #BetterMeds4Kids.
📖 Read more here👇 frontiersin.org/journals/ped…
Martina Penazzato retweeted
📢Join us at the 78th World Health Assembly for a high-level side event on advancing access to paediatric medicines!
📅 20 May 2025,
🕰️18:30–20:30 CET at Jardin de Penthes, Geneva
🚀Let's strengthen the global ecosystem for #children's #health together!
🔗bit.ly/43TYOG9
#WHA78 #BetterMeds4Kids #GlobalHealth
Martina Penazzato retweeted
Millions of kids lack access to age-appropriate meds.
The WHO's @GAP_f_Network is changing that—33 orgs working to deliver #BetterMeds4Kids, especially in LMICs.
Read more in this new paper via @LancetChildAdol 👇
doi.org/10.1016/S2352-4642(2…
#Access2Meds
Martina Penazzato retweeted
📢Just published in The Lancet Child & Adolescent Health!
"Simplifying medicine dosing for children by harmonising weight bands across therapeutic areas"
💊 A step toward simplifying and standardising paediatric treatment globally.
📄 Read: pubmed.ncbi.nlm.nih.gov/4011…
#ChildHealth #Bettermeds4kids #GAPf
To all manufacturers that are keen to contribute to a future where #BetterMeds4Kids are available where needed…two new TPPs are out and already included in the EOI! @MedsPatentPool @gardp_amr @valeria_gigante
📢 The Target Product Profiles for priority #paediatric formulations of azithromycin & nitrofurantoin are now available! 📄👇
🔗 bit.ly/4inEYHe
Interested #Manufacturers are invited to submit an EOI for product evaluation to #WHO
🔗 Please see bit.ly/3DljnQT
#Bettermeds4kids #Antibiotics
Don’t forget to join us today! We have some important updates to share! #BetterMeds4Kids @GAP_f_Network @WHO @gardp_amr @Penta_ID
📢 Save the date! Join us for our upcoming webinar on Investigating and developing better antibiotics for children: What Can We Do Now and Next?
📅 March 4, 2025
⏰1400-1500 CET
Register here 👉bit.ly/3CTjkLU
Martina Penazzato retweeted
Global health initiatives have transformed health outcomes for millions of people, especially women, children, and families living with HIV. But our work is not done.
Stand up with us, say ‘Global Health Cannot Wait.’
Martina Penazzato retweeted
What happens when HIV services are terminated?
When mothers have access to treatment, their risk of transmitting HIV to their babies is less than 1%. Global health cannot wait!
Martina Penazzato retweeted
"Stopping these programs is a death sentence for mothers and children."
Dr. Lynne Mofenson explains what is at risk for the +10,000 pregnant women impacted by the terminations of EGPAF's USAID work in Lesotho, Tanzania, and Eswatini.
Martina Penazzato retweeted
📢 Save the date! Join us for our upcoming webinar on Investigating and developing better antibiotics for children: What Can We Do Now and Next?
📅 March 4, 2025
⏰1400-1500 CET
Register here 👉bit.ly/3CTjkLU
Martina Penazzato retweeted
WHO expresses deep concern about the implications of the immediate funding pause for #HIV programmes in low- and middle-income countries.
These programmes provide access to life-saving HIV therapy to more than 30 million people worldwide.
A funding halt for HIV programmes can put people living with HIV at immediate increased risk of illness and death and undermine efforts to prevent transmission in communities and countries.
Such measures, if prolonged, could lead to rises in new infections and deaths, reversing decades of progress and potentially taking the world back to the 1980s and 1990s when millions died of HIV every year globally, including many in the United States of America.
For the global community, this could result in significant setbacks to progress in partnerships and investments in scientific advances that have been the cornerstone of good public health programming, including innovative diagnostics, affordable medicines, and community delivery models of HIV care.
We call on the Government of the United States of America to enable additional exemptions to ensure the delivery of lifesaving HIV treatment and care.
Read more bit.ly/42yxxIz
ALT WHO statement on potential global threat to people living with HIV
Martina Penazzato retweeted
#HealthForAll
For everyone. Everywhere.
ALT With you, for you. WHO remains committed to health for all.
Martina Penazzato retweeted
Dolutegravir has transformed HIV treatment for children. The Unitaid-funded PETITE DTG study is now testing innovative, easy-to-administer formulations like dissolvable films, making treatment more accessible for newborns.
Watch the story: youtube.com/watch?v=PIDZtgfs…
Together stronger for kids. On this #WorldChildrensDay we celebrate the partnership and collaborations we forged through the @GAP_f_Network and look to a future of sustained efforts for #BetterMeds4Kids @WHO
🌍 This #WorldChildrensDay, we are proud to share the GAP-f Phase 2 Progress Report! The 📰highlights progress, challenges, and lessons learned, preparing us for GAP-f's next strategic phase.
Read more here 👉 bit.ly/4exUvSl
Martina Penazzato retweeted
Are you attending #TropMed24 this week?
Join the @DNDi symposium on "Advancing research to improve treatment of #NTDs in children" on Friday at 13.45 to learn about our analysis of all registered clinical trials on #children targeting #NTDs
@Sarahcharnaud
#BetterMeds4Kids
Last day to help @WHO finalise these two important target product profiles! #BetterMeds4Kids @gardp_amr @Penta_ID @EGPAF @MedsPatentPool @UNICEF
📢Call for public consultation: Target product profile for paediatric formulation of Nitrofurantoin and Azithromycin
📅Deadline: 13 November
Find out more 👉Call for public consultation: Target product profile for paediatric formulation of Nitrofurantoin and Azithromycin (who.int)
🌍📢 WHO Call for Research Questions in Child Health! 👉bit.ly/48ovAiE
Let’s work together to create a healthier, brighter future for every child. 🌱👶 #ChildHealth #GlobalHealth #Research #WHO #childhealthresearch @JeremyFarrar @vaseemoorthy